CN113678979A - 用于促使ii型糖尿病人群胰岛素合成和分泌的固体饮料 - Google Patents
用于促使ii型糖尿病人群胰岛素合成和分泌的固体饮料 Download PDFInfo
- Publication number
- CN113678979A CN113678979A CN202110980718.1A CN202110980718A CN113678979A CN 113678979 A CN113678979 A CN 113678979A CN 202110980718 A CN202110980718 A CN 202110980718A CN 113678979 A CN113678979 A CN 113678979A
- Authority
- CN
- China
- Prior art keywords
- insulin
- secretion
- type
- synthesis
- solid beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title claims abstract description 40
- 235000013361 beverage Nutrition 0.000 title claims abstract description 21
- 102000004877 Insulin Human genes 0.000 title claims abstract description 20
- 108090001061 Insulin Proteins 0.000 title claims abstract description 20
- 229940125396 insulin Drugs 0.000 title claims abstract description 20
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 19
- 230000028327 secretion Effects 0.000 title claims abstract description 19
- 238000003786 synthesis reaction Methods 0.000 title claims abstract description 19
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title claims abstract description 17
- 230000001737 promoting effect Effects 0.000 title claims abstract description 16
- 239000007787 solid Substances 0.000 title claims abstract description 16
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000000284 extract Substances 0.000 claims abstract description 16
- 239000011701 zinc Substances 0.000 claims abstract description 13
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 13
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 11
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000011575 calcium Substances 0.000 claims abstract description 11
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 11
- 239000011591 potassium Substances 0.000 claims abstract description 11
- 229910052700 potassium Inorganic materials 0.000 claims abstract description 11
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 claims abstract description 8
- 241001608472 Bifidobacterium longum Species 0.000 claims abstract description 8
- 241000167854 Bourreria succulenta Species 0.000 claims abstract description 8
- 241001640002 Malpighia emarginata Species 0.000 claims abstract description 8
- 235000014837 Malpighia glabra Nutrition 0.000 claims abstract description 8
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 8
- 229940009291 bifidobacterium longum Drugs 0.000 claims abstract description 8
- 235000019693 cherries Nutrition 0.000 claims abstract description 8
- 229940013618 stevioside Drugs 0.000 claims abstract description 8
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000019202 steviosides Nutrition 0.000 claims abstract description 8
- 206010012601 diabetes mellitus Diseases 0.000 claims abstract description 6
- 241000193830 Bacillus <bacterium> Species 0.000 claims abstract description 4
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims abstract description 4
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims abstract description 4
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229960003975 potassium Drugs 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical group [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 claims description 3
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 3
- 229960005069 calcium Drugs 0.000 claims description 3
- 229940049920 malate Drugs 0.000 claims description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 3
- 229960003189 potassium gluconate Drugs 0.000 claims description 3
- 235000013926 potassium gluconate Nutrition 0.000 claims description 3
- 239000004224 potassium gluconate Substances 0.000 claims description 3
- 235000011478 zinc gluconate Nutrition 0.000 claims description 3
- 239000011670 zinc gluconate Substances 0.000 claims description 3
- 229960000306 zinc gluconate Drugs 0.000 claims description 3
- 238000000034 method Methods 0.000 claims 1
- 238000004806 packaging method and process Methods 0.000 claims 1
- 238000005303 weighing Methods 0.000 claims 1
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000667 effect on insulin Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了用于促使II型糖尿病人群胰岛素合成和分泌的固体饮料，属于糖尿病保健饮料技术领域，具体为一种用于促使II型糖尿病人群胰岛素合成和分泌的配方产品饮料，包括以下组分：苹果提取物APE‑60、长双歧杆菌、鼠李糖杆菌、针叶樱桃提取物、钙、钾、锌和甜菊糖T‑204；各组分重量比为：苹果提取物APE‑60为0.25‑0.85份、长双歧杆菌为0.02‑0.20份、鼠李糖杆菌为0.02‑0.20份、针叶樱桃提取物为0.2‑4份、钙为0.1‑0.5份、钾为0.1‑0.5份、锌为0.01‑0.05份、甜菊糖为0.01‑0.5份，每份重量为0.2‑3克。本发明的配方产品能够促使II型糖尿病人群胰岛素的合成和分泌，帮助患者早日康复。
Description
技术领域
本发明涉及固体饮料技术领域，具体为用于促使II型糖尿病人群胰岛素合成和分泌的固体饮料。
背景技术
II型糖尿病患者特征为高血糖、相对缺乏胰岛素、胰岛素抵抗等，饮食是影响II型糖尿病发病风险的重要因素，饮用过量的含糖饮料可增加患病风险，目前的保健饮料通常具有一定的降火滋阴，养颜作用，却不能适用于糖尿病病人，更没有可以促进糖尿病患者胰岛素合成和分泌的饮料。
发明内容
针对上述存在的技术不足，本发明的目的是提供用于促使II型糖尿病人群胰岛素合成和分泌的固体饮料，能够促使II型糖尿病人群胰岛素合成和分泌。
为解决上述技术问题，本发明采用如下技术方案：
本发明提供用于促使II型糖尿病人群胰岛素合成和分泌的固体饮料，包括以下组分：苹果提取物APE-60、长双歧杆菌、鼠李糖杆菌、针叶樱桃提取物、钙、钾、锌和甜菊糖T-204；各组分重量比为：苹果提取物APE-60为0.25-0.85份、长双歧杆菌为0.02-0.20份、鼠李糖杆菌为0.02-0.20份、针叶樱桃提取物为0.2-4份、钙为0.1-0.5份、钾为0.1-0.5份、锌为0.01-0.05份、甜菊糖为0.01-0.5份，每份重量为0.2-3克。优选的，所述钙为苹果酸二钙。
优选的，所述钾为葡萄糖酸钾。
优选的，所述锌为葡萄糖酸锌。
还涉及用于促使II型糖尿病人群胰岛素合成和分泌的固体饮料的制备方法，具体为：采用常规制剂方法将各组分制备成粉剂，分别准确称取各组分，充分混合均匀后，进行袋装。
本发明的有益效果在于：本发明的配方产品能够促使II型糖尿病人群胰岛素的合成和分泌，帮助患者早日康复。
具体实施方式
下面将对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例1，用于促使II型糖尿病人群胰岛素合成和分泌的固体饮料，包括以下组分：苹果提取物APE-60、长双歧杆菌、鼠李糖杆菌、针叶樱桃提取物、钙、钾、锌和甜菊糖T-204；各组分重量比为：苹果提取物APE-60为0.25-0.85份、长双歧杆菌为0.02-0.20份、鼠李糖杆菌为0.02-0.20份、针叶樱桃提取物为0.2-4份、钙为0.1-0.5份、钾为0.1-0.5份、锌为0.01-0.05份、甜菊糖为0.01-0.5份，每份重量为0.2-3克。
进一步的，所述钙为苹果酸二钙。
进一步的，所述钾为葡萄糖酸钾。
进一步的，所述锌为葡萄糖酸锌。
还涉及用于促使II型糖尿病人群胰岛素合成和分泌的固体饮料的制备方法，具体为：采用常规制剂方法将各组分制备成粉剂，分别准确称取各组分，充分混合均匀后，进行袋装。
其中锌对胰岛素信号的转导作用，锌代谢紊乱对于糖尿病的发展非常重要。
显然，本领域的技术人员可以对本发明进行各种改动和变型而不脱离本发明的精神和范围。这样，倘若本发明的这些修改和变型属于本发明权利要求及其等同技术的范围之内，则本发明也意图包含这些改动和变型在内。
Claims (5)
1.用于促使II型糖尿病人群胰岛素合成和分泌的固体饮料，其特征在于，包括以下组分：苹果提取物APE-60、长双歧杆菌、鼠李糖杆菌、针叶樱桃提取物、钙、钾、锌和甜菊糖T-204；各组分重量比为：苹果提取物APE-60为0.25-0.85份、长双歧杆菌为0.02-0.20份、鼠李糖杆菌为0.02-0.20份、针叶樱桃提取物为0.2-4份、钙为0.1-0.5份、钾为0.1-0.5份、锌为0.01-0.05份、甜菊糖为0.01-0.5份，每份重量为0.2-3克。
2.如权利要求1所述的用于促使II型糖尿病人群胰岛素合成和分泌的固体饮料，其特征在于，所述钙为苹果酸二钙。
3.如权利要求1所述的用于促使II型糖尿病人群胰岛素合成和分泌的固体饮料，其特征在于，所述钾为葡萄糖酸钾。
4.如权利要求1所述的用于促使II型糖尿病人群胰岛素合成和分泌的固体饮料，其特征在于，所述锌为葡萄糖酸锌。
5.如权利要求1所述的用于促使II型糖尿病人群胰岛素合成和分泌的固体饮料的制备方法，其特征在于，具体为：采用常规制剂方法将各组分制备成粉剂，分别准确称取各组分，充分混合均匀后，进行包装。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110980718.1A CN113678979A (zh) | 2021-08-25 | 2021-08-25 | 用于促使ii型糖尿病人群胰岛素合成和分泌的固体饮料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110980718.1A CN113678979A (zh) | 2021-08-25 | 2021-08-25 | 用于促使ii型糖尿病人群胰岛素合成和分泌的固体饮料 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113678979A true CN113678979A (zh) | 2021-11-23 |
Family
ID=78582384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110980718.1A Pending CN113678979A (zh) | 2021-08-25 | 2021-08-25 | 用于促使ii型糖尿病人群胰岛素合成和分泌的固体饮料 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113678979A (zh) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102458415A (zh) * | 2009-06-19 | 2012-05-16 | 丹尼斯科公司 | 治疗糖尿病及相关病症的双歧杆菌 |
-
2021
- 2021-08-25 CN CN202110980718.1A patent/CN113678979A/zh active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102458415A (zh) * | 2009-06-19 | 2012-05-16 | 丹尼斯科公司 | 治疗糖尿病及相关病症的双歧杆菌 |
Non-Patent Citations (3)
| Title |
|---|
| JOHN STAUGHTON: "7 Best Benefits of Acerola", 《HTTPS://WWW.ORGANICFACTS.NET/HEALTH-BENEFITS/FRUIT/ACEROLA.HTML》 * |
| 苗天翼: "苹果多酚基于GLP-1受体途径降糖作用的机制研究", 《中国优秀博硕士学位论文全文数据库(硕士)医药卫生科技辑》 * |
| 魏奇等: "姬松茸提取物的降血糖作用及对糖尿病大鼠肠道菌群的影响", 《中国食品学报》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5229390A (en) | Physiologically active dietetic composition | |
| CN103169006B (zh) | 宝宝营养面条及其制备方法 | |
| CN101218953B (zh) | 一种酸性奶冻食品及其制备方法 | |
| CN105360891A (zh) | 一种低血糖生成指数面粉及其制备方法 | |
| CN102008109A (zh) | 小麦胚芽蛋白饮料及制备方法 | |
| CN101940323A (zh) | 复合包埋夹心珠及其制备方法 | |
| WO2023040001A1 (zh) | 一种含有桑叶 dnj 和桑叶肽的组合物及其制备方法 | |
| CN105031042A (zh) | 一种具有减肥功能的药物组合物及其应用 | |
| CN113383808A (zh) | 一种含有茶粉的全麦面包及其制备方法 | |
| CN106819719B (zh) | 具有持续控制血糖功能的乳酸菌饮料及其制备方法 | |
| CN104365904A (zh) | 一种红枣养生保健茶酒及其制作方法 | |
| CN109007719A (zh) | 一种控糖型果冻及其制备方法 | |
| CN113678979A (zh) | 用于促使ii型糖尿病人群胰岛素合成和分泌的固体饮料 | |
| CN114766676A (zh) | 控制体重的片剂及其制备方法 | |
| JPH02154673A (ja) | 水溶性ダイエタリーファイバー含有飲料の製造方法 | |
| CN104621524A (zh) | 一种低热量复合代糖产品 | |
| CN113785878A (zh) | 一种花楸果酸奶饮品及其制备方法 | |
| CN100566594C (zh) | 杏仁粥及其制备方法 | |
| CN112042946A (zh) | 富含益生元的高钙组合物及其制备方法 | |
| CN115702654A (zh) | 辅助降血糖的中老年调制羊奶粉及制备方法 | |
| CN113575824A (zh) | 用于预防ii型糖尿病人群代谢综合征的固体饮料 | |
| CN101791107A (zh) | 一种甜菊糖和白糖的低热量组合糖 | |
| CN110089580A (zh) | 一种亚麻籽油 | |
| CN102166023A (zh) | 一种芹菜软饮料及其制作方法 | |
| KR102573871B1 (ko) | 헴프씨드를 이용한 콤부차의 제조방법 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211123 |